{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:17:52Z","timestamp":1783163872722,"version":"3.54.6"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81502963"],"award-info":[{"award-number":["81502963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Liaocheng University Funds","award":["318051538"],"award-info":[{"award-number":["318051538"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11531-4","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:14:05Z","timestamp":1775294045000},"page":"6255-6287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of anti-glioblastoma natural products based on andrographolide derivatives: efficiently identifying potential multi-target and multifunctional molecules through the integration of in silico methods and experimental verification"],"prefix":"10.1007","volume":"30","author":[{"given":"Ya-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan-Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Xia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"11531_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/b978-0-12-802997-8.00023-2","volume":"134","author":"HG Wirsching","year":"2016","unstructured":"Wirsching HG, Galanis E, Weller M (2016) Glioblastoma. Handb Clin Neurol 134:381\u2013397. https:\/\/doi.org\/10.1016\/b978-0-12-802997-8.00023-2","journal-title":"Handb Clin Neurol"},{"key":"11531_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"11531_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613","journal-title":"CA Cancer J Clin"},{"key":"11531_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK (2023) Glioblastoma and other primary brain malignancies in adults: a review. JAMA 329:574\u2013587. https:\/\/doi.org\/10.1001\/jama.2023.0023","journal-title":"JAMA"},{"key":"11531_CR5","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842\u20131850. https:\/\/doi.org\/10.1001\/jama.2013.280319","journal-title":"JAMA"},{"key":"11531_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/ane.13625","volume":"146","author":"P St\u00e5hl","year":"2022","unstructured":"St\u00e5hl P, Henoch I, Smits A, Rydenhag B, Ozanne A (2022) Quality of life in patients with glioblastoma and their relatives. Acta Neurol Scand 146:82\u201391. https:\/\/doi.org\/10.1111\/ane.13625","journal-title":"Acta Neurol Scand"},{"key":"11531_CR7","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1002\/anie.201601967","volume":"55","author":"Y Tu","year":"2016","unstructured":"Tu Y (2016) Artemisinin-a gift from traditional Chinese medicine to the world (Nobel lecture). Angew Chem Int Ed Engl 55:10210\u201310226. https:\/\/doi.org\/10.1002\/anie.201601967","journal-title":"Angew Chem Int Ed Engl"},{"key":"11531_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11684-021-0898-6","volume":"16","author":"Q Shi","year":"2022","unstructured":"Shi Q, Xia F, Wang Q, Liao F, Guo Q, Xu C, Wang J (2022) Discovery and repurposing of artemisinin. Front Med 16:1\u20139. https:\/\/doi.org\/10.1007\/s11684-021-0898-6","journal-title":"Front Med"},{"key":"11531_CR9","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.3390\/molecules29163886","volume":"29","author":"L Wen","year":"2024","unstructured":"Wen L, Chan BC, Qiu MH, Leung PC, Wong CK (2024) Artemisinin and its derivatives as potential anticancer agents. Molecules 29:3886. https:\/\/doi.org\/10.3390\/molecules29163886","journal-title":"Molecules"},{"key":"11531_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","volume":"176","author":"W Hou","year":"2019","unstructured":"Hou W, Liu B, Xu H (2019) Triptolide: medicinal chemistry, chemical biology and clinical progress. Eur J Med Chem 176:378\u2013392. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.032","journal-title":"Eur J Med Chem"},{"key":"11531_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114705","volume":"162","author":"J Song","year":"2023","unstructured":"Song J, He GN, Dai L (2023) A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes. Biomed Pharmacother 162:114705. https:\/\/doi.org\/10.1016\/j.biopha.2023.114705","journal-title":"Biomed Pharmacother"},{"key":"11531_CR12","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1039\/d4md00468j","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Li N, Wang Z, Wang S, Ren S, Li X (2024) Synthesis of a celastrol derivative as a cancer stem cell inhibitor through regulation of the STAT3 pathway for treatment of ovarian cancer. RSC Med Chem 15:3433\u20133443. https:\/\/doi.org\/10.1039\/d4md00468j","journal-title":"RSC Med Chem"},{"key":"11531_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejphar.2018.10.043","volume":"842","author":"X Li","year":"2019","unstructured":"Li X, Wang H, Ding J, Nie S, Wang L, Zhang L, Ren S (2019) Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells. Eur J Pharmacol 842:146\u2013156. https:\/\/doi.org\/10.1016\/j.ejphar.2018.10.043","journal-title":"Eur J Pharmacol"},{"key":"11531_CR14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1039\/d3fo05484e","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Zhao J, Wang X, Lin Z, Lin H, Lin Z (2024) Ginsenoside - a promising natural active ingredient with steroidal hormone activity. Food Funct 15:1825\u20131839. https:\/\/doi.org\/10.1039\/d3fo05484e","journal-title":"Food Funct"},{"key":"11531_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116559","volume":"230","author":"X Wang","year":"2024","unstructured":"Wang X, Li X, Zhang X, Wang X, Yang J, Liu G (2024) Design, synthesis and biological evaluation of novel curcumin-fluorouracil hybrids as potential anti-cancer agents. Biochem Pharmacol 230:116559. https:\/\/doi.org\/10.1016\/j.bcp.2024.116559","journal-title":"Biochem Pharmacol"},{"key":"11531_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110189","volume":"367","author":"Y Ma","year":"2022","unstructured":"Ma Y, Guo X, Wang Q, Liu T, Liu Q, Yang M, Jia A, Yang J, Liu G (2022) Anti-inflammatory effects of \u03b2-ionone-curcumin hybrid derivatives against ulcerative colitis. Chem Biol Interact 367:110189. https:\/\/doi.org\/10.1016\/j.cbi.2022.110189","journal-title":"Chem Biol Interact"},{"key":"11531_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2174\/1568026616666160927150452","volume":"17","author":"V Kishore","year":"2017","unstructured":"Kishore V, Yarla NS, Bishayee A, Putta S, Malla R, Neelapu NR, Challa S, Das S, Shiralgi Y, Hegde G, Dhananjaya BL (2017) Multi-targeting andrographolide and its natural analogs as potential therapeutic agents. Curr Top Med Chem 17:845\u2013857. https:\/\/doi.org\/10.2174\/1568026616666160927150452","journal-title":"Curr Top Med Chem"},{"key":"11531_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081638","author":"CH Yang","year":"2017","unstructured":"Yang CH, Yen TL, Hsu CY, Thomas PA, Sheu JR, Jayakumar T (2017) Multi-targeting andrographolide, a novel NF-\u03baB inhibitor, as a potential therapeutic agent for stroke. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18081638","journal-title":"Int J Mol Sci"},{"key":"11531_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010005","author":"RA Burgos","year":"2020","unstructured":"Burgos RA, Alarc\u00f3n P, Quiroga J, Manosalva C, Hancke J (2020) Andrographolide, an anti-inflammatory multitarget drug: all roads lead to cellular metabolism. Molecules. https:\/\/doi.org\/10.3390\/molecules26010005","journal-title":"Molecules"},{"key":"11531_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1039\/d0np00049c","volume":"38","author":"QTN Tran","year":"2021","unstructured":"Tran QTN, Tan WSD, Wong WSF, Chai CLL (2021) Polypharmacology of andrographolide: beyond one molecule one target. Nat Prod Rep 38:682\u2013692. https:\/\/doi.org\/10.1039\/d0np00049c","journal-title":"Nat Prod Rep"},{"key":"11531_CR21","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","volume":"59","author":"Y Dai","year":"2019","unstructured":"Dai Y, Chen SR, Chai L, Zhao J, Wang Y, Wang Y (2019) Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr 59:S17-s29. https:\/\/doi.org\/10.1080\/10408398.2018.1501657","journal-title":"Crit Rev Food Sci Nutr"},{"key":"11531_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/fcp.12757","volume":"36","author":"P Agrawal","year":"2022","unstructured":"Agrawal P, Nair MS (2022) An insight into the pharmacological and analytical potential of Andrographolide. Fundam Clin Pharmacol 36:586\u2013600. https:\/\/doi.org\/10.1111\/fcp.12757","journal-title":"Fundam Clin Pharmacol"},{"key":"11531_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ptr.7324","volume":"36","author":"B Zeng","year":"2022","unstructured":"Zeng B, Wei A, Zhou Q, Yuan M, Lei K, Liu Y, Song J, Guo L, Ye Q (2022) Andrographolide: a review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches. Phytother Res 36:336\u2013364. https:\/\/doi.org\/10.1002\/ptr.7324","journal-title":"Phytother Res"},{"key":"11531_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117438","volume":"180","author":"J Hu","year":"2024","unstructured":"Hu J, Li Y, Xie X, Song Y, Yan W, Luo Y, Jiang Y (2024) The therapeutic potential of Andrographolide in cancer treatment. Biomed Pharmacother 180:117438. https:\/\/doi.org\/10.1016\/j.biopha.2024.117438","journal-title":"Biomed Pharmacother"},{"key":"11531_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2025.2450783","author":"V Sharma","year":"2025","unstructured":"Sharma V, Kumar G, Kumar P, Khajuria R, Nemiwal M (2025) Innovative anticancer molecule andrographolide: a concise review of its pharmacological targets. Nat Prod Res. https:\/\/doi.org\/10.1080\/14786419.2025.2450783","journal-title":"Nat Prod Res"},{"key":"11531_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000503410","volume":"105","author":"L Zhang","year":"2020","unstructured":"Zhang L, Bao M, Liu B, Zhao H, Zhang Y, Ji X, Zhao N, Zhang C, He X, Yi J, Tan Y, Li L, Lu C (2020) Effect of Andrographolide and its analogs on bacterial infection: a review. Pharmacology 105:123\u2013134. https:\/\/doi.org\/10.1159\/000503410","journal-title":"Pharmacology"},{"key":"11531_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s1875-5364(20)60016-4","volume":"18","author":"R Latif","year":"2020","unstructured":"Latif R, Wang CY (2020) Andrographolide as a potent and promising antiviral agent. Chin J Nat Med 18:760\u2013769. https:\/\/doi.org\/10.1016\/s1875-5364(20)60016-4","journal-title":"Chin J Nat Med"},{"key":"11531_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154537","volume":"109","author":"X Qin","year":"2023","unstructured":"Qin X, Wang X, Tian M, Dong Z, Wang J, Wang C, Huang Q (2023) The role of Andrographolide in the prevention and treatment of liver diseases. Phytomedicine 109:154537. https:\/\/doi.org\/10.1016\/j.phymed.2022.154537","journal-title":"Phytomedicine"},{"key":"11531_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109078","volume":"117","author":"J Lu","year":"2019","unstructured":"Lu J, Ma Y, Wu J, Huang H, Wang X, Chen Z, Chen J, He H, Huang C (2019) A review for the neuroprotective effects of Andrographolide in the central nervous system. Biomed Pharmacother 117:109078. https:\/\/doi.org\/10.1016\/j.biopha.2019.109078","journal-title":"Biomed Pharmacother"},{"key":"11531_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpha.2023.05.010","volume":"13","author":"T Gou","year":"2023","unstructured":"Gou T, Hu M, Xu M, Chen Y, Chen R, Zhou T, Liu J, Guo L, Ao H, Ye Q (2023) Novel wine in an old bottle: preventive and therapeutic potentials of Andrographolide in atherosclerotic cardiovascular diseases. J Pharm Anal 13:563\u2013589. https:\/\/doi.org\/10.1016\/j.jpha.2023.05.010","journal-title":"J Pharm Anal"},{"key":"11531_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/13880209.2013.836544","volume":"52","author":"R Bera","year":"2014","unstructured":"Bera R, Ahmed SK, Sarkar L, Sen T, Karmakar S (2014) Pharmacokinetic analysis and tissue distribution of Andrographolide in rat by a validated LC-MS\/MS method. Pharm Biol 52:321\u2013329. https:\/\/doi.org\/10.3109\/13880209.2013.836544","journal-title":"Pharm Biol"},{"key":"11531_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/s19102275","author":"SP Chiu","year":"2019","unstructured":"Chiu SP, Batsaikhan B, Huang HM, Wang JY (2019) Application of electric cell-substrate impedance sensing to unvestigate the cytotoxic effects of andrographolide on U-87 MG glioblastoma cell migration and apoptosis. Sensors (Basel). https:\/\/doi.org\/10.3390\/s19102275","journal-title":"Sensors (Basel)"},{"key":"11531_CR33","doi-asserted-by":"publisher","first-page":"105860","DOI":"10.18632\/oncotarget.22407","volume":"8","author":"SL Yang","year":"2017","unstructured":"Yang SL, Kuo FH, Chen PN, Hsieh YH, Yu NY, Yang WE, Hsieh MJ, Yang SF (2017) Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1\/2-mediated matrix metalloproteinase-2 expression. Oncotarget 8:105860\u2013105872. https:\/\/doi.org\/10.18632\/oncotarget.22407","journal-title":"Oncotarget"},{"key":"11531_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196686","author":"NS Othman","year":"2022","unstructured":"Othman NS, Mohd Azman DK (2022) Andrographolide induces G2\/M cell cycle arrest and apoptosis in human glioblastoma DBTRG-05MG cell line via ERK1\/2 \/c-Myc\/p53 signaling pathway. Molecules. https:\/\/doi.org\/10.3390\/molecules27196686","journal-title":"Molecules"},{"key":"11531_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114688","volume":"379","author":"J Geng","year":"2019","unstructured":"Geng J, Liu J, Yuan X, Liu W, Guo W (2019) Andrographolide triggers autophagy-mediated inflammation inhibition and attenuates chronic unpredictable mild stress (CUMS)-induced depressive-like behavior in mice. Toxicol Appl Pharmacol 379:114688. https:\/\/doi.org\/10.1016\/j.taap.2019.114688","journal-title":"Toxicol Appl Pharmacol"},{"key":"11531_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nep.12172","volume":"19","author":"WX Zhang","year":"2014","unstructured":"Zhang WX, Zhang ZM, Zhang ZQ, Wang Y, Zhou W (2014) Andrographolide induced acute kidney injury: analysis of 26 cases reported in Chinese literature. Nephrology (Carlton) 19:21\u201326. https:\/\/doi.org\/10.1111\/nep.12172","journal-title":"Nephrology (Carlton)"},{"key":"11531_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.etap.2016.02.004","volume":"45","author":"LL Gu","year":"2016","unstructured":"Gu LL, Zhang XY, Xing WM, Xu JD, Lu H (2016) Andrographolide-induced apoptosis in human renal tubular epithelial cells: roles of endoplasmic reticulum stress and inflammatory response. Environ Toxicol Pharmacol 45:257\u2013264. https:\/\/doi.org\/10.1016\/j.etap.2016.02.004","journal-title":"Environ Toxicol Pharmacol"},{"key":"11531_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2741\/e732","volume":"7","author":"SK Mishra","year":"2015","unstructured":"Mishra SK, Tripathi S, Shukla A, Oh SH, Kim HM (2015) Andrographolide and analogues in cancer prevention. Front Biosci (Elite Ed) 7:255\u2013266. https:\/\/doi.org\/10.2741\/e732","journal-title":"Front Biosci (Elite Ed)"},{"key":"11531_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ejmech.2019.05.022","volume":"176","author":"SGS Kandanur","year":"2019","unstructured":"Kandanur SGS, Tamang N, Golakoti NR, Nanduri S (2019) Andrographolide: a natural product template for the generation of structurally and biologically diverse diterpenes. Eur J Med Chem 176:513\u2013533. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.022","journal-title":"Eur J Med Chem"},{"key":"11531_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113710","volume":"224","author":"H Zhang","year":"2021","unstructured":"Zhang H, Li S, Si Y, Xu H (2021) Andrographolide and its derivatives: current achievements and future perspectives. Eur J Med Chem 224:113710. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113710","journal-title":"Eur J Med Chem"},{"key":"11531_CR41","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11011-017-0091-4","volume":"32","author":"E Kornelius","year":"2017","unstructured":"Kornelius E, Li HH, Peng CH, Hsiao HW, Yang YS, Huang CN, Lin CL (2017) Mevastatin promotes neuronal survival against A\u03b2-induced neurotoxicity through AMPK activation. Metab Brain Dis 32:1999\u20132007. https:\/\/doi.org\/10.1007\/s11011-017-0091-4","journal-title":"Metab Brain Dis"},{"key":"11531_CR42","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1016\/j.bmcl.2004.06.090","volume":"14","author":"S Nanduri","year":"2004","unstructured":"Nanduri S, Nyavanandi VK, Thunuguntla SS, Kasu S, Pallerla MK, Ram PS, Rajagopal S, Kumar RA, Ramanujam R, Babu JM, Vyas K, Devi AS, Reddy GO, Akella V (2004) Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents. Bioorg Med Chem Lett 14:4711\u20134717. https:\/\/doi.org\/10.1016\/j.bmcl.2004.06.090","journal-title":"Bioorg Med Chem Lett"},{"key":"11531_CR43","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1016\/j.tetlet.2004.04.142","volume":"45","author":"S Nanduri","year":"2004","unstructured":"Nanduri S, Nyavanandi VK, Thunuguntla SSR, Velisoju M, Kumar RA, Rajagopalan R (2004) Novel routes for the generation of structurally diverse labdane diterpenes from andrographolide. Tetrahedron Lett 45:4883\u20134886. https:\/\/doi.org\/10.1016\/j.tetlet.2004.04.142","journal-title":"Tetrahedron Lett"},{"key":"11531_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14756360500499988","volume":"21","author":"SR Jada","year":"2006","unstructured":"Jada SR, Hamzah AS, Lajis NH, Saad MS, Stevens MF, Stanslas J (2006) Semisynthesis and cytotoxic activities of andrographolide analogues. J Enzyme Inhib Med Chem 21:145\u2013155. https:\/\/doi.org\/10.1080\/14756360500499988","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11531_CR45","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.phytochem.2006.11.031","volume":"68","author":"SR Jada","year":"2007","unstructured":"Jada SR, Subur GS, Matthews C, Hamzah AS, Lajis NH, Saad MS, Stevens MF, Stanslas J (2007) Semisynthesis and in vitro anticancer activities of andrographolide analogues. Phytochemistry 68:904\u2013912. https:\/\/doi.org\/10.1016\/j.phytochem.2006.11.031","journal-title":"Phytochemistry"},{"key":"11531_CR46","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1016\/j.bmcl.2010.09.126","volume":"20","author":"B Das","year":"2010","unstructured":"Das B, Chowdhury C, Kumar D, Sen R, Roy R, Das P, Chatterjee M (2010) Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent. Bioorg Med Chem Lett 20:6947\u20136950. https:\/\/doi.org\/10.1016\/j.bmcl.2010.09.126","journal-title":"Bioorg Med Chem Lett"},{"key":"11531_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.molcatb.2009.11.002","volume":"62","author":"X He","year":"2010","unstructured":"He X, Zeng X, Hu H, Wu YJ (2010) Cytotoxic biotransformed products from andrographolide by Rhizopus stolonifer ATCC 12939. J Mol Catal B Enzym 62:242\u2013247. https:\/\/doi.org\/10.1016\/j.molcatb.2009.11.002","journal-title":"J Mol Catal B Enzym"},{"key":"11531_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molcatb.2010.09.017","volume":"68","author":"X He","year":"2011","unstructured":"He X, Wang Y, Hu H, Wu Y, Zeng X (2011) Novel bioconversion products of andrographolide by Aspergillus ochraceus and their cytotoxic activities against human tumor cell lines. J Mol Catal B Enzym 68:89\u201393. https:\/\/doi.org\/10.1016\/j.molcatb.2010.09.017","journal-title":"J Mol Catal B Enzym"},{"key":"11531_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.lfs.2010.12.019","volume":"88","author":"JP Ooi","year":"2011","unstructured":"Ooi JP, Kuroyanagi M, Sulaiman SF, Muhammad TS, Tan ML (2011) Andrographolide and 14-deoxy-11, 12-didehydroandrographolide inhibit cytochrome P450s in HepG2 hepatoma cells. Life Sci 88:447\u2013454. https:\/\/doi.org\/10.1016\/j.lfs.2010.12.019","journal-title":"Life Sci"},{"key":"11531_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bmcl.2011.11.085","volume":"22","author":"U Sirion","year":"2012","unstructured":"Sirion U, Kasemsook S, Suksen K, Piyachaturawat P, Suksamrarn A, Saeeng R (2012) New substituted C-19-andrographolide analogues with potent cytotoxic activities. Bioorg Med Chem Lett 22:49\u201352. https:\/\/doi.org\/10.1016\/j.bmcl.2011.11.085","journal-title":"Bioorg Med Chem Lett"},{"key":"11531_CR51","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1016\/j.bmcl.2013.04.010","volume":"23","author":"D Chen","year":"2013","unstructured":"Chen D, Song Y, Lu Y, Xue X (2013) Synthesis and in vitro cytotoxicity of andrographolide-19-oic acid analogues as anti-cancer agents. Bioorg Med Chem Lett 23:3166\u20133169. https:\/\/doi.org\/10.1016\/j.bmcl.2013.04.010","journal-title":"Bioorg Med Chem Lett"},{"key":"11531_CR52","first-page":"230","volume":"7","author":"C Gong","year":"2013","unstructured":"Gong C, Xu C, Ji L, Wang Z (2013) A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38\/ERK1\/2 signal pathway. Biosci Trends 7:230\u2013236","journal-title":"Biosci Trends"},{"key":"11531_CR53","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.bmcl.2013.05.061","volume":"23","author":"S Wei","year":"2013","unstructured":"Wei S, Tang YB, Hua H, Ohkoshi E, Goto M, Wang LT, Lee KH, Xiao Z (2013) Discovery of novel andrographolide derivatives as cytotoxic agents. Bioorg Med Chem Lett 23:4056\u20134060. https:\/\/doi.org\/10.1016\/j.bmcl.2013.05.061","journal-title":"Bioorg Med Chem Lett"},{"key":"11531_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cbi.2014.04.020","volume":"218","author":"K Shen","year":"2014","unstructured":"Shen K, Ji L, Lu B, Xu C, Gong C, Morahan G, Wang Z (2014) Andrographolide inhibits tumor angiogenesis via blocking VEGFA\/VEGFR2-MAPKs signaling cascade. Chem Biol Interact 218:99\u2013106. https:\/\/doi.org\/10.1016\/j.cbi.2014.04.020","journal-title":"Chem Biol Interact"},{"key":"11531_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/cbdd.12246","volume":"83","author":"C Tang","year":"2014","unstructured":"Tang C, Gu G, Wang B, Deng X, Zhu X, Qian H, Huang W (2014) Design, synthesis, and biological evaluation of andrographolide derivatives as potent hepatoprotective agents. Chem Biol Drug Des 83:324\u2013333. https:\/\/doi.org\/10.1111\/cbdd.12246","journal-title":"Chem Biol Drug Des"},{"key":"11531_CR56","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s10637-014-0105-6","volume":"32","author":"CC Wong","year":"2014","unstructured":"Wong CC, Periasamy N, Sagineedu SR, Sidik S, Sumon SH, Loadman P, Phillips R, Lajis NH, Stanslas J (2014) In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog. Invest New Drugs 32:806\u2013814. https:\/\/doi.org\/10.1007\/s10637-014-0105-6","journal-title":"Invest New Drugs"},{"key":"11531_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127741","volume":"33","author":"R Bunthawong","year":"2021","unstructured":"Bunthawong R, Sirion U, Chairoungdua A, Suksen K, Piyachaturawat P, Suksamrarn A, Saeeng R (2021) Synthesis and cytotoxic activity of new 7-acetoxy-12-amino-14-deoxy andrographolide analogues. Bioorg Med Chem Lett 33:127741. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127741","journal-title":"Bioorg Med Chem Lett"},{"key":"11531_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104941","volume":"112","author":"W Cai","year":"2021","unstructured":"Cai W, Li J, Chen C, Wu J, Li J, Xue X (2021) Design, synthesis, and anticancer evaluation of novel andrographolide derivatives bearing an \u03b1,\u03b2-unsaturated ketone moiety. Bioorg Chem 112:104941. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104941","journal-title":"Bioorg Chem"},{"key":"11531_CR59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/07391102.2018.1448721","volume":"37","author":"N Wang","year":"2019","unstructured":"Wang N, Ren JX, Xie Y (2019) Identification of novel DHFR inhibitors for treatment of tuberculosis by combining virtual screening with in vitro activity assay. J Biomol Struct Dyn 37:1054\u20131061. https:\/\/doi.org\/10.1080\/07391102.2018.1448721","journal-title":"J Biomol Struct Dyn"},{"key":"11531_CR60","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.jcim.0c00598","volume":"61","author":"RM Stein","year":"2021","unstructured":"Stein RM, Yang Y, Balius TE, O\u2019Meara MJ, Lyu J, Young J, Tang K, Shoichet BK, Irwin JJ (2021) Property-unmatched decoys in docking benchmarks. J Chem Inf Model 61:699\u2013714. https:\/\/doi.org\/10.1021\/acs.jcim.0c00598","journal-title":"J Chem Inf Model"},{"key":"11531_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25051107","author":"JX Ren","year":"2020","unstructured":"Ren JX, Zhang RT, Zhang H (2020) Identifying novel ATX inhibitors via combinatory virtual screening using crystallography-derived pharmacophore modelling, docking study, and QSAR analysis. Molecules. https:\/\/doi.org\/10.3390\/molecules25051107","journal-title":"Molecules"},{"key":"11531_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140905","volume":"1324","author":"Y-L Li","year":"2025","unstructured":"Li Y-L, Mao J, Tian X-F, Song H, Ren J-X (2025) Identification of Salvianolic acid A as a potent inhibitor of PDEs to enhance proliferation of human neural stem cells. J Mol Struct 1324:140905. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140905","journal-title":"J Mol Struct"},{"issue":"Suppl 4","key":"11531_CR63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000174688","volume":"77","author":"AW Alberts","year":"1990","unstructured":"Alberts AW (1990) Lovastatin and simvastatin-inhibitors of HMG CoA reductase and cholesterol biosynthesis. Cardiology 77(Suppl 4):14\u201321. https:\/\/doi.org\/10.1159\/000174688","journal-title":"Cardiology"},{"key":"11531_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang Y, Li M, Wang J, Pan Y, Wu FX (2015) CytoNCA: a Cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems 127:67\u201372. https:\/\/doi.org\/10.1016\/j.biosystems.2014.11.005","journal-title":"Biosystems"},{"key":"11531_CR65","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.biopha.2016.07.048","volume":"83","author":"JX Ren","year":"2016","unstructured":"Ren JX, Gao NN, Cao XS, Hu QA, Xie Y (2016) Homology modeling and virtual screening for inhibitors of lipid kinase PI(4)K from Plasmodium. Biomed Pharmacother 83:798\u2013808. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.048","journal-title":"Biomed Pharmacother"},{"key":"11531_CR66","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.biopha.2016.09.034","volume":"84","author":"JX Ren","year":"2016","unstructured":"Ren JX, Zhang RT, Zhang H, Cao XS, Liu LK, Xie Y (2016) Identification of novel VP35 inhibitors: virtual screening driven new scaffolds. Biomed Pharmacother 84:199\u2013207. https:\/\/doi.org\/10.1016\/j.biopha.2016.09.034","journal-title":"Biomed Pharmacother"},{"key":"11531_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11185-8","author":"YL Li","year":"2025","unstructured":"Li YL, Mao J, Cheng Z, Zhou XY, Zhang DN, Li YZ, Cao ZX, Ren JX (2025) Identification of low-toxicity DNA topoisomerase I inhibitors with potential blood-brain barrier penetrability for glioblastoma therapy: structure-based virtual screening reveals promising novel scaffolds. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-025-11185-8","journal-title":"Mol Divers"},{"key":"11531_CR68","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.biopha.2017.02.064","volume":"89","author":"JX Ren","year":"2017","unstructured":"Ren JX, Cheng Z, Huang YX, Zhao JF, Guo P, Zou ZM, Xie Y (2017) Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking. Biomed Pharmacother 89:376\u2013385. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.064","journal-title":"Biomed Pharmacother"},{"key":"11531_CR69","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748. https:\/\/doi.org\/10.1006\/jmbi.1996.0897","journal-title":"J Mol Biol"},{"key":"11531_CR70","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.fct.2018.09.051","volume":"121","author":"H Zhang","year":"2018","unstructured":"Zhang H, Ma JX, Liu CT, Ren JX, Ding L (2018) Development and evaluation of in silico prediction model for drug-induced respiratory toxicity by using na\u00efve Bayes classifier method. Food Chem Toxicol 121:593\u2013603. https:\/\/doi.org\/10.1016\/j.fct.2018.09.051","journal-title":"Food Chem Toxicol"},{"key":"11531_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11030-018-9882-8","volume":"23","author":"H Zhang","year":"2019","unstructured":"Zhang H, Ren JX, Ma JX, Ding L (2019) Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier. Mol Divers 23:381\u2013392. https:\/\/doi.org\/10.1007\/s11030-018-9882-8","journal-title":"Mol Divers"},{"key":"11531_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-026-03005-7","author":"P Piera L\u00edndez","year":"2026","unstructured":"Piera L\u00edndez P, Danielsen LS, Kova\u010di\u0107 I, Pielies Avell\u00ed M, Nesme J, Jensen LJ, Andersen JN, S\u00f8rensen SJ, Rasmussen S (2026) Accurate plasmid reconstruction from metagenomics data using assembly-alignment graphs and contrastive learning. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-026-03005-7","journal-title":"Nat Biotechnol"},{"key":"11531_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073674","author":"C Feng","year":"2022","unstructured":"Feng C, Anger EE, Zhang X, Su S, Su C, Zhao S, Yu F, Li J (2022) Protective effects of mitochondrial uncoupling protein 2 against aristolochic acid I-induced toxicity in HK-2 cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073674","journal-title":"Int J Mol Sci"},{"key":"11531_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02392-3","volume":"19","author":"T Lu","year":"2022","unstructured":"Lu T, Li H, Zhou Y, Wei W, Ding L, Zhan Z, Liu W, Tao J, Xue X (2022) Neuroprotective effects of alisol A 24-acetate on cerebral ischaemia-reperfusion injury are mediated by regulating the PI3K\/AKT pathway. J Neuroinflammation 19:37. https:\/\/doi.org\/10.1186\/s12974-022-02392-3","journal-title":"J Neuroinflammation"},{"key":"11531_CR75","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1600-0773.1995.tb01048.x","volume":"77","author":"P Oms","year":"1995","unstructured":"Oms P, Assie N, Bruniquel F, Degryse AD, van Haverbeke G, Delhon A (1995) Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate. Pharmacol Toxicol 77:391\u2013396. https:\/\/doi.org\/10.1111\/j.1600-0773.1995.tb01048.x","journal-title":"Pharmacol Toxicol"},{"key":"11531_CR76","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s0735-1097(02)02030-2","volume":"40","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC Jr., Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C (2002) ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 40:567\u2013572. https:\/\/doi.org\/10.1016\/s0735-1097(02)02030-2","journal-title":"J Am Coll Cardiol"},{"key":"11531_CR77","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.amjcard.2004.12.042","volume":"95","author":"RL Wortmann","year":"2005","unstructured":"Wortmann RL, Tipping RW, Levine JG, Melin JM (2005) Frequency of myopathy in patients receiving lovastatin. Am J Cardiol 95:983\u2013985. https:\/\/doi.org\/10.1016\/j.amjcard.2004.12.042","journal-title":"Am J Cardiol"},{"key":"11531_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173891","author":"DS Gesto","year":"2020","unstructured":"Gesto DS, Pereira CMS, Cerqueira N, Sousa SF (2020) An atomic-level perspective of HMG-CoA-reductase: the target enzyme to treat hypercholesterolemia. Molecules. https:\/\/doi.org\/10.3390\/molecules25173891","journal-title":"Molecules"},{"key":"11531_CR79","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1038\/onc.2012.6","volume":"31","author":"JW Clendening","year":"2012","unstructured":"Clendening JW, Penn LZ (2012) Targeting tumor cell metabolism with statins. Oncogene 31:4967\u20134978. https:\/\/doi.org\/10.1038\/onc.2012.6","journal-title":"Oncogene"},{"key":"11531_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02041-2","volume":"40","author":"W Jiang","year":"2021","unstructured":"Jiang W, Hu JW, He XR, Jin WL, He XY (2021) Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res 40:241. https:\/\/doi.org\/10.1186\/s13046-021-02041-2","journal-title":"J Exp Clin Cancer Res"},{"key":"11531_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1615\/jenvironpatholtoxicoloncol.v30.i1.40","volume":"30","author":"P Pratheeshkumar","year":"2011","unstructured":"Pratheeshkumar P, Kuttan G (2011) Andrographolide inhibits human umbilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 during angiogenesis. J Environ Pathol Toxicol Oncol 30:33\u201341. https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.v30.i1.40","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"11531_CR82","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3892\/etm.2013.1196","volume":"6","author":"W Luo","year":"2013","unstructured":"Luo W, Liu Y, Zhang J, Luo X, Lin C, Guo J (2013) Andrographolide inhibits the activation of NF-\u03baB and MMP-9 activity in H3255 lung cancer cells. Exp Ther Med 6:743\u2013746. https:\/\/doi.org\/10.3892\/etm.2013.1196","journal-title":"Exp Ther Med"},{"key":"11531_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00280-023-04626-4","volume":"93","author":"J Zeng","year":"2024","unstructured":"Zeng J, Zheng Y, Dong S, Ding T, Zhang S, Li K, Liu H, Fang Q, Yuan S, Wei Y, Li J, Liu T (2024) Andrographolide inhibits Burkitt\u2019s lymphoma by binding JUN and CASP3 proteins. Cancer Chemother Pharmacol 93:381\u2013391. https:\/\/doi.org\/10.1007\/s00280-023-04626-4","journal-title":"Cancer Chemother Pharmacol"},{"key":"11531_CR84","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1134\/s1607672921050070","volume":"500","author":"H Gao","year":"2021","unstructured":"Gao H, Li H, Liu W, Mishra SK, Li C (2021) Andrographolide induces apoptosis in gastric cancer cells through reactivation of p53 and inhibition of Mdm-2. Dokl Biochem Biophys 500:393\u2013401. https:\/\/doi.org\/10.1134\/s1607672921050070","journal-title":"Dokl Biochem Biophys"},{"key":"11531_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108833","volume":"179","author":"E Larriba","year":"2024","unstructured":"Larriba E, de Juan Romero C, Garc\u00eda-Mart\u00ednez A, Quintanar T, Rodr\u00edguez-Lescure \u00c1, Soto JL, Saceda M, Mart\u00edn-Nieto J, Barber\u00e1 VM (2024) Identification of new targets for glioblastoma therapy based on a DNA expression microarray. Comput Biol Med 179:108833. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108833","journal-title":"Comput Biol Med"},{"key":"11531_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100796","author":"RP Czekay","year":"2024","unstructured":"Czekay RP, Higgins CE, Aydin HB, Samarakoon R, Subasi NB, Higgins SP, Lee H, Higgins PJ (2024) SERPINE1: role in cholangiocarcinoma progression and a therapeutic target in the desmoplastic microenvironment. Cells. https:\/\/doi.org\/10.3390\/cells13100796","journal-title":"Cells"},{"key":"11531_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1126\/science.7716522","volume":"268","author":"S Maignan","year":"1995","unstructured":"Maignan S, Guilloteau JP, Fromage N, Arnoux B, Becquart J, Ducruix A (1995) Crystal structure of the mammalian Grb2 adaptor. Science 268:291\u2013293. https:\/\/doi.org\/10.1126\/science.7716522","journal-title":"Science"},{"key":"11531_CR88","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1006\/jmbi.2000.4396","volume":"306","author":"S Yuzawa","year":"2001","unstructured":"Yuzawa S, Yokochi M, Hatanaka H, Ogura K, Kataoka M, Miura K, Mandiyan V, Schlessinger J, Inagaki F (2001) Solution structure of Grb2 reveals extensive flexibility necessary for target recognition. J Mol Biol 306:527\u2013537. https:\/\/doi.org\/10.1006\/jmbi.2000.4396","journal-title":"J Mol Biol"},{"key":"11531_CR89","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jmb.2005.08.037","volume":"353","author":"J Phan","year":"2005","unstructured":"Phan J, Shi ZD, Burke TR Jr., Waugh DS (2005) Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain. J Mol Biol 353:104\u2013115. https:\/\/doi.org\/10.1016\/j.jmb.2005.08.037","journal-title":"J Mol Biol"},{"key":"11531_CR90","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10858-008-9272-0","volume":"42","author":"K Ogura","year":"2008","unstructured":"Ogura K, Shiga T, Yokochi M, Yuzawa S, Burke TR Jr., Inagaki F (2008) Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor. J Biomol NMR 42:197\u2013207. https:\/\/doi.org\/10.1007\/s10858-008-9272-0","journal-title":"J Biomol NMR"},{"key":"11531_CR91","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/0929866525666171123213148","volume":"24","author":"M Ijaz","year":"2018","unstructured":"Ijaz M, Wang F, Shahbaz M, Jiang W, Fathy AH, Nesa EU (2018) The role of Grb2 in cancer and peptides as Grb2 antagonists. Protein Pept Lett 24:1084\u20131095. https:\/\/doi.org\/10.2174\/0929866525666171123213148","journal-title":"Protein Pept Lett"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11531-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11531-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11531-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:05Z","timestamp":1783161545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11531-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":91,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11531"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11531-4","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}